We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DSTKF:BISTDestek Finans Faktoring A.S. Analysis

Data as of 2026-05-24 - not real-time

TRY 1,987.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading well below its 20‑day and 50‑day SMAs (2411 and 2139), with a bearish MACD histogram and an RSI hovering around 39, indicating oversold conditions but still a down‑trend. Recent price action has been volatile, swinging from 2.73k to 2.50k in early May and now sitting near 1.99k, while trading volume has been on the rise, suggesting heightened market attention. The broader market sentiment is in an "Extreme Greed" phase (fear‑greed index 91.6), which may be artificially inflating the price despite weak fundamentals. Fundamentally, the company appears severely overvalued, with a trailing P/E of 149 versus an industry average of 16.8, and a price‑to‑book ratio above 54. Debt levels are alarming, with a debt‑to‑equity ratio exceeding 230 and total debt far outweighing cash reserves, while operating and free cash flows are deeply negative. Profitability metrics look superficially strong (ROE ~44%), but the cash‑flow picture and capital structure raise serious concerns. The combination of high volatility (30‑day volatility > 70%), a negative beta (inverse market correlation), and a historic max drawdown of nearly 48% underscores the stock's risk profile. Given the lack of dividend payouts and the absence of analyst coverage, there is little income cushion for investors. In summary, market enthusiasm is at odds with a fundamentally fragile balance sheet and an overextended valuation, making the stock a high‑risk proposition in the current environment.
The technical outlook suggests short‑term pressure, while the fundamental backdrop points to a potential correction once sentiment normalizes. Investors should be wary of the heavy debt burden, negative cash generation, and the disconnect between price and earnings. The sector’s regulatory environment and Turkey’s macro‑economic volatility further amplify the risk, implying that any upside is likely limited and contingent on a substantive turnaround in cash‑flow performance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and low RSI
  • Rising volatility and negative market beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Extremely high valuation multiples
  • Heavy debt load with negative cash flows
  • Uncertain macro‑economic environment in Turkey

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential for restructuring or capital infusion
  • Sector exposure to regulatory changes
  • Absence of dividend income to offset risk

Key Metrics & Analysis

Financial Health

Revenue Growth15.30%
Profit Margin53.68%
P/E Ratio149.3
ROE44.82%
ROA19.32%
Debt/Equity234.81
P/B Ratio54.3
Op. Cash FlowTRY-4528328192
Free Cash FlowTRY-12879446016
Industry P/E16.8

Technical Analysis

TrendBullish
RSI39.3
SupportTRY 1,704.00
ResistanceTRY 2,895.00
MA 20TRY 2,411.48
MA 50TRY 2,138.97
MA 200TRY 1,095.92
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta-0.50
Volatility74.61%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.